St. Jude Medical, Inc. (STJ) Tops Q3 EPS by 2c, Guides In-Line; to Buyback $300M in Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
William Blair Downgrades St. Jude Medical (STJ) to Market Perform
October 18, 2012 7:05 AM EDTWilliam Blair downgraded St. Jude Medical (NYSE: STJ) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on... More
UPDATE: Canaccord Genuity Downgrades St. Jude Medical (STJ) to Hold, Weak Top-Line
October 18, 2012 6:58 AM EDT(Updated - October 18, 2012 8:55 AM EDT)
Canaccord Genuity downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold and cut its price target from $50 to $43 following Q3 results.
"We downgrade our rating on STJ from Buy to HOLD. We reduce our... More
Goldman Sachs Downgrades St. Jude Medical (STJ) to Neutral, Growth Deferred
October 18, 2012 6:53 AM EDTGoldman Sachs downgraded St. Jude Medical (NYSE: STJ) from Buy to Neutral with a price target of $42.00 (from $48.00).
"The companys core business is facing greater headwinds than we had contemplated; while new growth drivers are gaining traction at a slower... More
